High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
- $1,500,000
- Not stated
- Jan 17, 2024
Official announcement on nih_guide+grants_gov · opens the funder's page. Always confirm dates there.
Summary
The purpose of this notice of funding opportunity (NOFO) is to support high priority research at the intersection of HIV and substance use. […]
Other topics in this solicitation
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The scoring framework for this mechanism — we have not extracted per-criterion detail for this specific announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
More in infectious-disease
Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India
Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Plant Protection Act Section 7721 Plant Pest and Disease Management and Disaster Prevention Program (PPDMDPP)
$400k